Henan Taloph Pharmaceutical Stock Co.,Ltd

SSE:600222.SS

5.87 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 1,941.422,069.9091,960.6941,604.5171,417.0971,311.8151,194.7941,168.391953.3071,017.3811,254.231,304.6751,089.131980.782913.303813.144612.738371.161364.543251.323204.04170.449181.813136.082139.923167.561136.718155.7398.28
Cost of Revenue 1,444.5611,505.1861,488.6141,141.451,042.225827.453792.644812.927645.849774.5821,004.7721,051.377906.112855.039798.204701.194517.08290.533286.903173.186128.18684.77592.58662.7654.12977.67857.71257.88135.38
Gross Profit 496.859564.722472.081463.067374.872484.362402.15355.464307.458242.798249.458253.298183.018125.742115.099111.94995.65780.62877.6478.13775.85485.67389.22873.32285.79389.88379.00697.8562.9
Gross Profit Ratio 0.2560.2730.2410.2890.2650.3690.3370.3040.3230.2390.1990.1940.1680.1280.1260.1380.1560.2170.2130.3110.3720.5030.4910.5390.6130.5360.5780.6280.64
Reseach & Development Expenses 100.891127.714116.5256.49663.66559.38658.11740.64941.2718.290.7820.7970.0040.0030.65800000000000000
General & Administrative Expenses 34.21246.40146.82739.81938.9836.63330.36722.77635.05823.74216.40412.79712.4829.21610.69933.530.87323.05726.38527.8322.55422.2225.91816.18912.79111.5939.94211.22411.89
Selling & Marketing Expenses 109.626140.46183.025131.277102.259176.978137.069115.65276.61671.86472.62274.50656.37742.16637.32726.99423.91720.17121.99619.16723.81843.61738.54617.21621.424.62812.06821.36713.453
SG&A 143.838351.354229.852171.095141.239213.611167.437138.427111.67495.60689.02687.30368.85951.38248.02660.49454.7943.22848.38146.99746.37165.83764.46433.40434.19136.22122.0132.59125.343
Other Expenses 216.41138.31183.08478.38157.55675.963-2.229-11.3553.7362.2960.97946.1765.77613.3377.4816.1037.8161.73213.60710.6837.9399.044-0.156-0.39.637-0.331-1.2067.1241.519
Operating Expenses 461.139517.38429.456305.973262.46348.959318.752266.997233.738189.489142.021145.113113.65685.50576.50662.80956.78545.25949.97647.77547.82967.71166.4535.07535.71337.49223.02933.94626.555
Operating Income 35.71944.16727.464130.771119.94139.555-113.11121.8577.356-8.55764.20663.61435.43214.18927.27431.36618.66724.50115.21919.64519.3417.57815.18233.5145.48545.64839.60237.15314.743
Operating Income Ratio 0.0180.0210.0140.0820.0850.106-0.0950.0190.008-0.0080.0510.0490.0330.0140.030.0390.030.0660.0420.0780.0950.0440.0840.2460.3250.2720.290.2390.15
Total Other Income Expenses Net -0.645-1.204-110.313-28.158-90.7-91.719-189.08-11.3553.0561.4010.9713.375-28.972-11.696-4.924-9.251-10.084-9.135-10.019-10.76-9.4459.035-0.161-0.3542.711-0.331-1.7067.1241.519
Income Before Tax 35.07442.962-82.8497.4529.2451.234-115.34110.50210.412-7.15765.17766.98941.17527.52634.75437.45226.42226.23316.21119.60518.58516.61315.02133.15650.82245.31737.89644.27616.262
Income Before Tax Ratio 0.0180.021-0.0420.0050.0210.039-0.0970.0090.011-0.0070.0520.0510.0380.0280.0380.0460.0430.0710.0440.0780.0910.0970.0830.2440.3630.270.2770.2840.165
Income Tax Expense -18.421-1.867-7.1330.6711.6446.2690.1173.1348.559-11.56215.00415.2859.1396.6396.9315.8922.3284.9261.5883.5943.8024.7284.34.1577.9486.8765.7086.8711.622
Net Income 50.52543.557-75.7165.99529.24145.712-115.3185.1274.0165.55732.03536.0620.19912.75124.27230.14723.16820.69318.03617.04416.24814.77210.91429.08642.87438.44132.18837.40614.641
Net Income Ratio 0.0260.021-0.0390.0040.0210.035-0.0970.0040.0040.0050.0260.0280.0190.0130.0270.0370.0380.0560.0490.0680.080.0870.060.2140.3060.2290.2350.240.149
EPS 0.0910.077-0.130.0110.0540.08-0.20.0090.0070.010.0650.0810.0490.0310.0590.0730.0560.050.0320.0320.030.0270.020.0540.0750.0710.0780.0910.036
EPS Diluted 0.0910.077-0.130.0110.0540.08-0.20.0090.0070.010.0650.0810.0490.0310.0590.0730.0560.050.0320.0320.030.0270.020.0540.0750.0710.0780.0910.036
EBITDA 102.514111.80890.448187.956142.46198.65141.38967.87763.8843.637108.03108.87877.88357.74161.07170.47458.2954.0343.96946.11343.19838.60836.66548.71159.2456.11256.65663.90336.345
EBITDA Ratio 0.0530.0540.0460.1170.1010.0750.1180.0580.0670.0430.0860.0830.0720.0590.0670.0870.0950.1460.1210.1830.2120.2270.2020.3580.4230.3350.4140.410.37